rs119480072
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001349206.2(LPIN1):c.1270C>T(p.Arg424Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000167 in 1,613,798 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001349206.2 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LPIN1 | NM_001349206.2 | c.1270C>T | p.Arg424Ter | stop_gained | 9/21 | ENST00000674199.1 | NP_001336135.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LPIN1 | ENST00000674199.1 | c.1270C>T | p.Arg424Ter | stop_gained | 9/21 | NM_001349206.2 | ENSP00000501331 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152188Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251496Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135922
GnomAD4 exome AF: 0.0000123 AC: 18AN: 1461610Hom.: 0 Cov.: 31 AF XY: 0.0000151 AC XY: 11AN XY: 727130
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152188Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74358
ClinVar
Submissions by phenotype
Myoglobinuria, acute recurrent, autosomal recessive Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Sep 11, 2021 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 01, 2008 | - - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 18, 2023 | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 4911). This premature translational stop signal has been observed in individuals with early onset autosomal recessive myoglobinuria (PMID: 18817903, 23928362, 26909335, 32410653). This variant is present in population databases (rs119480072, gnomAD 0.02%). This sequence change creates a premature translational stop signal (p.Arg388*) in the LPIN1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LPIN1 are known to be pathogenic (PMID: 18817903, 20583302, 22481384, 26111941). - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Aug 15, 2018 | The R388X variant in the LPIN1 gene has been reported previously in association with autosomal recessive acute recurrent myoglobinuria when present in the homozygous state or when in trans with another disease-causing variant (Zeharia et al., 2008; Michot et al., 2010; Jaradat et al., 2016). This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The R388X variant is observed in 9/277,250 (0.0032%) global alleles in large population cohorts and no individuals were reported to be homozygous (Lek et al., 2016). We interpret R388X as a pathogenic variant. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at